We analyzed the effect of COVID-19 on healthcare demand and invasive pneumococcal disease in children in Catalonia, Spain. Compared with 2018-2019, we noted large reductions in healthcare activities and incidence of invasive pneumococcal disease in 2020. These changes likely resulted from nonpharmaceutical measures implemented during the COVID-19 pandemic.
Keywords: 13-valent pneumococcal conjugate vaccine; COVID-19; Catalonia; SARS-CoV-2; Spain; bacteria; coronavirus disease; invasive pneumococcal disease; nonpharmaceutical measures; respiratory infections; serotype; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.